FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

430242005: Regadenoson (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2708658015 Regadenoson (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2765897017 Regadenoson en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regadenoson Is a Substance with adenosine A2 receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Regadenoson Is a Pyrazole derivative true Inferred relationship Existential restriction modifier
Regadenoson Is a Purine nucleoside true Inferred relationship Existential restriction modifier
Regadenoson Has disposition Adenosine A2 receptor agonist true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Regadenoson 0.08mg/mL injection solution 5mL prefilled syringe Has active ingredient False Regadenoson Inferred relationship Existential restriction modifier
Regadenoson 0.08mg/mL injection solution 5mL vial Has active ingredient False Regadenoson Inferred relationship Existential restriction modifier
Product containing regadenoson Has active ingredient True Regadenoson Inferred relationship Existential restriction modifier 1
Regadenoson Has active ingredient True Regadenoson Inferred relationship Existential restriction modifier 1
Product containing precisely regadenoson 80 microgram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Regadenoson Inferred relationship Existential restriction modifier 1
Product containing precisely regadenoson 80 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Regadenoson Inferred relationship Existential restriction modifier 1
Product containing regadenoson in parenteral dose form (medicinal product form) Has active ingredient True Regadenoson Inferred relationship Existential restriction modifier 1
Product containing only regadenoson in parenteral dose form (medicinal product form) Has active ingredient True Regadenoson Inferred relationship Existential restriction modifier 1
Regadenoson 400micrograms/5ml solution for injection vials Has active ingredient False Regadenoson Inferred relationship Existential restriction modifier
Regadenoson 400micrograms/5ml solution for injection vials Has specific active ingredient True Regadenoson Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has active ingredient True Regadenoson Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) Has specific active ingredient True Regadenoson Inferred relationship Existential restriction modifier
Regadenoson 400micrograms/5ml solution for injection vials 1 vial Has specific active ingredient True Regadenoson Inferred relationship Existential restriction modifier
Rapiscan 400micrograms/5ml solution for injection vials (GE Healthcare Ltd) 1 vial Has specific active ingredient True Regadenoson Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start